Why is NAMS Up Today?
About NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor...
Overall Confidence: 60%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -0.5%
Market Comparison
🔔 Get NAMS Alerts
We'll notify you when NAMS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
NAMS has moved more than 3.0% up on 44 occasions in the past year.
Frequently Asked Questions
Why is NAMS stock up today?
This stock is significantly outperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.
Is NAMS stock a buy or sell right now?
Based on current analysis, NAMS shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the NAMS stock price target?
NAMS is currently trading at $22.86. Based on today's momentum, the expected short-term range is $22.40 - $23.55. See long-term price prediction →
Will NAMS stock continue rising?
Our analysis shows a 45% probability that NAMS's move continues in the next 1-3 days. Key level to watch: $24.00 (resistance).
Is NAMS stock oversold or overbought?
NAMS's RSI (Relative Strength Index) is currently at 31.7. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for NAMS stock?
NAMS's 10-day momentum indicator is at -3.99. Strong bearish momentum - the stock is experiencing significant downward pressure. Watch for potential reversal signals.
Is NAMS outperforming or underperforming the market?
NAMS (+4.57%) is currently significantly outperforming the market (+3.7% vs SPY). Today, the S&P 500 (SPY) is up 0.85%, and Nasdaq (QQQ) is up 0.87%.
What does MACD indicate for NAMS?
NAMS's MACD (-1.44) is currently below the signal line (-1.13), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 44.2) is strong.
Is NAMS in an uptrend or downtrend?
Based on moving average analysis, NAMS is in a bearish trend. The price ($22.86) is trading below both the 20-day SMA ($25.99) and 50-day SMA ($28.78). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis